Subscribe to our Newsletters !!
Drug quality is defined not only how a drug is man
Eppendorf is launching the new VisioNize® box 2,
The journey and merging of sperm and egg cells is
This year, the Hamburg based life sciences company
Alembic Pharmaceutica
Since it’s an ingredient in so many foods, you h
In a world constantly in motion, Microbioz India r
Britain has signed deals to procure 90 million doses of 2 possible COVID-19 vaccines in the Pfizer Inc and BioNTech alliance and French group Valneva, the company ministry said on Monday.
Britain had procured 30 million doses of the experimental BioNTech/Pfizer vaccine, and a deal in principle for 60 million doses of this Valneva vaccine, using an alternative of 40 million more doses if it had been demonstrated to be secure, effective and suitable, the ministry said.
Financial terms of the deals were not confirmed.
“This new venture with some of the world’s leading pharmaceutical and vaccine companies ensure the UK has the best chance possible of securing a vaccine which protects those most at risk,” business minister Alok Sharma said.
The deals follow a previously announced agreement with AstraZeneca for the company to produce 100 million doses of its potential vaccine being developed in partnership with the University of Oxford.
There’s presently no functioning bacterium from COVID-19, the disorder caused by the novel coronavirus, and specialists say one will be necessary to control the outbreak that has infected millions of individuals around the world and killed over 600,000.
Britain also said on Monday it had procured treatments containing COVID-19-neutralising antibodies from AstraZeneca to protect individuals who can’t be vaccinated.
